Related Experiment Videos
Increased telomerase activity in mouse skin premalignant progression
A Bednarek1, I Budunova, T J Slaga
1Department of Carcinogenesis, University of Texas M. D. Anderson Cancer Center, Smithville 78957, USA.
Cancer Research
|October 15, 1995
Summary
Telomerase activity is crucial for cellular immortality and cancer development. In a mouse skin cancer model, telomerase expression progressively increased with tumor progression, suggesting its role in premalignant lesions.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Telomerase, a ribonucleoprotein enzyme, is essential for overcoming cellular senescence and maintaining immortality in malignant tumors.
- Telomerase activity is typically absent in human adult tissues but present in various murine tissues.
- Mouse skin normally exhibits no telomerase activity.
Purpose of the Study:
- To investigate telomerase activity during premalignant and malignant progression in a mouse skin chemical carcinogenesis model.
- To correlate telomerase expression levels with the stage and characteristics of tumor development.
Main Methods:
- Utilized the mouse skin chemical carcinogenesis system, a model for premalignant and malignant progression.
- Assayed telomerase activity at different stages using the telomeric repeat amplification protocol (TRAP).
Main Results:
- Initially, only one of 11 papillomas showed high telomerase activity at 10 weeks.
- Increased telomerase activity was observed in more papillomas at 20 weeks.
- By 30 weeks, 100% of papillomas exhibited significantly elevated telomerase levels.
- Progressive telomerase upregulation correlated with increased genomic instability and phenotypic progression (aneuploidy, dysplasia).
Conclusions:
- The mouse skin carcinogenesis model demonstrates a progressive increase in telomerase activity associated with tumor progression.
- Elevated telomerase activity appears linked to genomic instability and phenotypic changes in premalignant lesions.
- This model is valuable for studying anti-telomerase therapeutic strategies.